BCAL Diagnostics

BCAL Diagnostics Book Value per Share

The Book Value per Share of BCAL Diagnostics (BDX.AX) as of Oct 18, 2026 is 0.02 AUD. In the previous year, Book Value per Share was 0.02 AUD — a change of -27.57% (lower).

Book Value per Share

0.02AUD

YoY

-27.57%

Last updated:

Book Value per Share of BCAL Diagnostics is 2025 0.02 AUD. Book Value per Share of BCAL Diagnostics was 2024 0.02 AUD. It decreases by -27.57% lower compared to the previous year.

The BCAL Diagnostics Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
-0.00 AUD
Jan 1, 2019
0.00 AUD
Jan 1, 2020
0.00 AUD
Jan 1, 2021
0.01 AUD
Jan 1, 2022
0.03 AUD
Jan 1, 2023
0.01 AUD
Jan 1, 2024
0.02 AUD
Jan 1, 2025
0.02 AUD
The BCAL Diagnostics Book Value per Share history
YEARBook Value per ShareYoY
0.02AUD-27.57%
0.02AUD+64.72%
0.01AUD-45.91%
0.03AUD+167.26%
0.01AUD+721.80%
0.00AUD-10.10%
0.00AUD-696.09%
-0.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BCAL Diagnostics stock

Book Value per Share of BCAL Diagnostics is 0.02 AUD in 2025.

Book Value per Share of BCAL Diagnostics changed from 0.02 AUD to 0.02 AUD, representing a -27.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — BCAL Diagnostics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — BCAL Diagnostics